share_log

盘中速览 | 三大指数集体上涨,科网股、半导体股走势强劲

Intraday quick overview | The three major indices rose collectively, with strong trends in SciNet stocks and semiconductor stocks

富途資訊 ·  Aug 4, 2022 10:50

Futu News on August 4, Hong Kong stocks continued to rebound today, with the three major indexes rising collectively.As of press time, the Hang Seng Index is up 1.66%, the Hang Seng Technology Index is up 2.58%, and the State-owned Enterprises Index is up 1.7%.

The collective strength of science and Internet stocksBilibili Inc. rose by more than 6%, BABA and JD.com by more than 5%, Meituan by nearly 4%, Tencent by nearly 3% and Kuaishou Technology by more than 2%.

Apple Inc's concept stock pulls upGao Wei ElectronicsIncrease by more than 12%BYDElectronics up 9%Sunny Optical TechnologyUp nearly 6%Qiu Ti science and technologyIncrease by more than 5%AAC Technologies Holdings Inc.Up nearly 4%.

Pharmaceutical outsourcing concept stocks strengthenKailiying rose by more than 9%, Genscript Biotech Corporation, Wuxi Apptec and Wuxi Biologics by more than 4%, and Tigermed by nearly 4%.

The semiconductor sector continues to rise.Hua Hong Semiconductor is up 5%, Semiconductor Manufacturing International Corporation is up nearly 5%, and Shanghai Fudan is up more than 3%.

Internet medical sector pulls upAlibaba Health Information Technology rose by more than 5%, JD Health and Zhongan Online by more than 2%.

The concept of tobacco has risen collectively.BYD Electronic rose 8%, Smoore International Holdings Limited. China Tobacco rose more than 2% in Hong Kong.

Most auto stocks are up.Geely Automobile rose by more than 5%, Byd Company Limited by more than 2% and NIO Inc. by more than 1%.

Individual stocks$BABA-SW (09988.HK) $Increased by nearly 5%. On the news, BABA announced the appointment.Xishen XingyeLi Yunlian and Wu Gangping, former chairman of Ernst & Young China, are independent directors of the group board of directors.

$Geely Automobile (00175.HK) $It rose nearly 5%, the delivery volume of polar krypton continued to climb, and southward funds bought net for three consecutive days.

$Wuxi Biologics (02269.HK) $Increased by nearly 4%, and reached a strategic cooperation with AstraZeneca PLC on COVID-19 's localization production of neutralizing antibodies.

Edit / somer

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment